Articles with public access mandates - Linda C. ChenLearn more
Not available anywhere: 2
Platinum‐based regimens versus cetuximab in definitive chemoradiation for human papillomavirus‐unrelated head and neck cancer
TH Beckham, C Barney, E Healy, AR Wolfe, A Branstetter, A Yaney, ...
International journal of cancer 147 (1), 107-115, 2020
Mandates: US National Institutes of Health
Current considerations for radiotherapy in HPV‐associated head and neck cancer
L Chen, N Riaz, N Lee, S McBride
Journal of Surgical Oncology 124 (6), 945-951, 2021
Mandates: US National Institutes of Health
Available somewhere: 25
Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection
L Chen, H Guerrero-Cazares, X Ye, E Ford, T McNutt, L Kleinberg, M Lim, ...
International Journal of Radiation Oncology* Biology* Physics 86 (4), 616-622, 2013
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Distinguishing true progression from radionecrosis after stereotactic radiation therapy for brain metastases with machine learning and radiomics
L Peng, V Parekh, P Huang, DD Lin, K Sheikh, B Baker, T Kirschbaum, ...
International Journal of Radiation Oncology* Biology* Physics 102 (4), 1236-1243, 2018
Mandates: US National Institutes of Health
IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform
PA Darrah, ST Hegde, DT Patel, RWB Lindsay, L Chen, M Roederer, ...
Journal of Experimental Medicine 207 (7), 1421-1433, 2010
Mandates: US National Institutes of Health
Glioblastoma recurrence patterns near neural stem cell regions
L Chen, KL Chaichana, L Kleinberg, X Ye, A Quinones-Hinojosa, ...
Radiotherapy and Oncology 116 (2), 294-300, 2015
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
K Li, JA Tandurella, J Gai, Q Zhu, SJ Lim, DL Thomas, T Xia, G Mo, ...
Cancer Cell 40 (11), 1374-1391. e7, 2022
Mandates: US National Institutes of Health, German Research Foundation
Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirus–associated oropharyngeal carcinoma treated with definitive …
CJ Tsai, SM McBride, N Riaz, JJ Kang, DJ Spielsinger, T Waldenberg, ...
JAMA oncology 8 (3), 364-372, 2022
Mandates: US National Institutes of Health
Toxicity profiles and survival outcomes among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated …
X Li, S Kitpanit, A Lee, D Mah, K Sine, EJ Sherman, LA Dunn, LS Michel, ...
JAMA Network Open 4 (6), e2113205-e2113205, 2021
Mandates: US National Institutes of Health
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer
JJ Kang, Y Yu, L Chen, K Zakeri, DY Gelblum, SM McBride, N Riaz, ...
CA: a cancer journal for clinicians 73 (2), 164-197, 2023
Mandates: US National Institutes of Health
Temporal lobe necrosis in head and neck cancer patients after proton therapy to the skull base
S Kitpanit, A Lee, KL Pitter, D Fan, JCH Chow, B Neal, Z Han, P Fox, ...
International journal of particle therapy 6 (4), 17-28, 2020
Mandates: US National Institutes of Health
Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer
K Fujiwara, MT Saung, H Jing, B Herbst, MK Zarecki, S Muth, A Wu, ...
Journal for Immunotherapy of cancer 8 (2), 2020
Mandates: US National Institutes of Health
Evaluation of proton therapy reirradiation for patients with recurrent head and neck squamous cell carcinoma
A Lee, R Woods, A Mahfouz, S Kitpanit, O Cartano, N Mohamed, ...
JAMA network open 6 (1), e2250607-e2250607, 2023
Mandates: US National Institutes of Health
Toxicity profiles and survival outcomes among patients with nonmetastatic oropharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated …
I Youssef, J Yoon, N Mohamed, K Zakeri, RH Press, L Chen, DY Gelblum, ...
JAMA Network Open 5 (11), e2241538-e2241538, 2022
Mandates: US National Institutes of Health
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers
D Fan, JJ Kang, M Fan, H Wang, A Lee, Y Yu, L Chen, CJ Tsai, ...
Oral oncology 104, 104641, 2020
Mandates: US National Institutes of Health
Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer
B Shrestha, Y Sun, F Faisal, V Kim, K Soares, A Blair, JM Herman, ...
Cancer medicine 6 (7), 1552-1562, 2017
Mandates: US National Institutes of Health
Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approach
R Xiao, RR Joshi, Q Husain, JR Cracchiolo, N Lee, J Tsai, Y Yu, L Chen, ...
Head & neck 41 (10), 3551-3563, 2019
Mandates: US National Institutes of Health
Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy
K Zakeri, H Wang, JJ Kang, A Lee, P Romesser, N Mohamed, D Gelblum, ...
Head & neck 43 (4), 1056-1062, 2021
Mandates: US National Institutes of Health
TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence
Y Yu, D Fan, X Song, K Zakeri, L Chen, J Kang, S McBride, CJ Tsai, ...
JCO Precision Oncology 5, 1259-1269, 2021
Mandates: US National Institutes of Health
Brief report: Robo1 regulates the migration of human subventricular zone neural progenitor cells during development
H Guerrero-Cazares, E Lavell, L Chen, P Schiapparelli, ...
Stem cells 35 (7), 1860-1865, 2017
Mandates: US National Institutes of Health, Howard Hughes Medical Institute …
Publication and funding information is determined automatically by a computer program